Medacta Hosts Inaugural Capital Markets Day, Showcasing Responsible Innovation and Effective Growth Strategy

CASTEL SAN PIETRO, Switzerland, September 30, 2024 - Medacta Group SA (SIX: MOVE) held its first Capital Markets Day on September 25, 2024, at its headquarters in Switzerland. Over 100 participants attended both in-person and online to gain insights into the company's history, growth strategy, innovative products, and financial outlook.

CEO Francesco Siccardi expressed pleasure in welcoming investors, analysts, and stakeholders to foster deeper connections and share the company’s vision. He emphasized Medacta's dedication to patient-focused, minimally invasive solutions and ongoing sustainable growth in the orthopedic market.

Founder and President Dr. Alberto Siccardi also welcomed attendees, sharing the family's entrepreneurial legacy and his personal experience as a hip surgery patient.

CFO Corrado Farsetta announced the mid-term guidance: a top-line growth CAGR in the low double-digits and an Adjusted EBITDA margin targeted around the 2024 result, excluding currency effects.

The event included presentations on Medacta’s innovative product lines, market expansion strategies, and corporate social responsibility initiatives, underscoring the company’s commitment to making a positive global impact through the Medacta for Life Foundation.